AKT1 and breast cancer: Currently, research regarding the PI3K–AKT pathway is primarily focused on cardio-cerebral-vascular disease, tumorigenesis [21], ovarian dysplasia, and breast cancer [22], and has not yet been applied to perimenopausal syndrome studies.